C91.5

Applicable To

• Acute variant of adult T-cell lymphoma/leukemia HTLV-1-associated)

• Chronic variant of adult T-cell lymphoma/leukemia HTLV-1-associated)

• Lymphomatoid variant of adult T-cell lymphoma/leukemia HTLV-1-associated)

• Smouldering variant of adult T-cell lymphoma/leukemia HTLV-1-associated)

Clinical Information

• A peripheral mature) t-cell neoplasm caused by the human t-cell leukemia virus type 1 htlv-1). Adult t-cell leukemia/lymphoma is endemic in several regions of the world, in particular japan, the caribbean, and parts of central africa. who, 2001)

• Aggressive t-cell malignancy with adult onset, caused by human t lymphotropic virus type 1.

• Aggressive t-cell malignancy with adult onset, caused by human t-lymphotropic virus 1. It is endemic in japan, the caribbean basin, southeastern United States, hawaii, and parts of central and south america and sub-saharan africa.

• An aggressive fast-growing) type of t-cell non-hodgkin lymphoma caused by the human t-cell leukemia virus type 1 htlv-1). It is marked by bone and skin lesions, high calcium levels, and enlarged lymph nodes, spleen, and liver.

• Atll. A cancer of t-cells a type of white blood cell). It is often associated with human t-cell leukemia virus htlv) infection.

Details

• C91.5 should not be used for reimbursement purposes as there are multiple codes below it that contain a greater level of detail.

• The 2023 edition of ICD-10-CM C91.5 became effective on October 1, 2022.

• This is the American ICD-10-CM version of C91.5 – other international versions of ICD-10 C91.5 may differ.